VAL WARNER: Open Payments
NPI 1366819575 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,972 in 172 payments from 27 companies in 2025. Trend: 2023 $2,637 · 2024 $4,080 · 2025 $12,972
Speaker / faculty: $9,690Food & beverage: $2,607Consulting: $675
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $10,615 |
| ABBVIE INC. | 47 | $633 |
| Amgen Inc. | 21 | $296 |
| Axsome Therapeutics, Inc. | 12 | $197 |
| Novo Nordisk Inc | 12 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $132 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Sumitomo Pharma America, Inc. | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Lilly USA, LLC | 4 | $64 |
Products named: NURTEC ODT, ZAVZPRET, VRAYLAR, Sunosi, OTEZLA, EVENITY, CAPLYTA, REXULTI.
Industry payments across UT — which companies pay providers there.
